Welcome to
Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.
Learn MoreAntiretroviral
Genvoya® is a tablet that contains 4 medicines used to treat infection caused by the human immunodeficiency virus (HIV). The 4 medicines are called elvitegravir (Vitekta), cobicistat (Tybost), emtricitabine (Emtriva), and tenofovir alafenamide. Elvitegravir is a medicine that belongs to a group called integrase inhibitors. Emtricitabine and tenofovir alafenamide belong to a group called nucleoside reverse transcriptase inhibitors (NRTIs), and cobicistat is an enhancer. Genvoya can slow down how soon you will see symptoms of HIV or slow the damage caused by HIV, but it cannot cure HIV infection. Genvoya tablets contain 150 mg of elvitegravir, 150 mg of cobicistat, 200 mg of emtricitabine, and 10 mg of tenofovir alafenamide.
Symptoms of an allergic reaction include: rash, hives, itching, chills, fever, headache, muscle ache, shortness of breath, coughing, tightness in the throat, swelling of the face or neck.
Not all patients who take Genvoya® will experience these side effects. Common side effects are bolded, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Find more information on side effects.
During the first few weeks of therapy, some people taking Genvoya develop a skin rash and 2 or more of the following symptoms:
If you develop a rash during the first few weeks of therapy and you have 2 or more of these symptoms, stop taking Genvoya right away and call your doctor or nurse. You should not take Genvoya again unless the doctor tells you to do so.
Be sure to discuss all questions and instructions with your doctor or pharmacist.